XML 67 R57.htm IDEA: XBRL DOCUMENT
v3.25.1

Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Castle Creek (Details) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended |
--- | --- | --- | ---
Feb. 28, 2025 USD ($) $ / shares shares | Mar. 31, 2025 USD ($) | Mar. 31, 2024 USD ($) | Dec. 31, 2024 USD ($)
Agreements |  |  |  |
Long-term royalty and commercial payment receivables under the cost recovery method |  | $ 59,916 |  | $ 55,936
Short-term royalty and commercial payment receivables under the cost recovery method |  | 413 |  | $ 413
Payments of consideration under RPAs, AAAs and CPPAs |  | 8,000 | $ 15,000 |
Fair value of warrants |  | 605 |  |
Royalty Financing Transaction | Castle Creek Biosciences, Inc |  |  |  |
Agreements |  |  |  |
Rights entity acquired as a percentage of specified percentage | 6.70% |  |  |
Percentage of domestic sales | 8.75% |  |  |
Percentage of worldwide sales | 8.00% |  |  |
Percentage of proceeds from potential PRV | 20.00% |  |  |
Number of warrants received | shares | 10,464 |  |  |
Exercise price of warrants received (in dollars per share) | $ / shares | $ 215.03 |  |  |
Term of warrants received | 10 years |  |  |
Aggregate purchase price | $ 5,000 |  |  |
Long-term royalty and commercial payment receivables under the cost recovery method | 4,400 |  |  |
Allowance for credit losses |  | $ 0 |  |
Fair value of warrants | $ 600 |  |  |
Royalty Financing Transaction | Castle Creek Biosciences, Inc | Volatility |  |  |  |
Agreements |  |  |  |
Derivative Asset, Measurement Input | 1.28 |  |  |
Royalty Financing Transaction | Castle Creek Biosciences, Inc | Risk-free interest rate |  |  |  |
Agreements |  |  |  |
Derivative Asset, Measurement Input | 0.042 |  |  |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13 + Details
Name: | us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Value of input used to measure derivative asset. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 103 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_DerivativeAssetMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Subparagraph (c) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireProductiveAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of warrants or rights received during the period to purchase shares of counterparty under the agreement. + References No definition available. + Details
Name: | xoma_AssetAcquisitionClassOfWarrantOrRightNumberReceived
Namespace Prefix: | xoma_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share of warrants or rights received to purchase shares of counterparty under the agreement. + References No definition available. + Details
Name: | xoma_AssetAcquisitionClassOfWarrantOrRightPricePerShare
Namespace Prefix: | xoma_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period over which entity has right to exercise warrants or rights received to purchase shares of counterparty under the agreement. + References No definition available. + Details
Name: | xoma_AssetAcquisitionClassOfWarrantOrRightTerm
Namespace Prefix: | xoma_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of investment in warrants, classified as noncurrent. + References No definition available. + Details
Name: | xoma_InvestmentWarrantsNoncurrent
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of cash outflow for consideration under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), Commercial payment purchase agreement (CPPAs) and other agreements classified as investing activities. Payments may include upfront payments, one-time payments, milestone payments and contingent consideration payments. + References No definition available. + Details
Name: | xoma_PaymentOfConsiderationUnderAgreementsInvestingActivities
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The rights entity acquired as a percentage of specified percentage of net sales or as a specified percentage of proceeds from potential Priority Review Voucher. + References No definition available. + Details
Name: | xoma_RightsReceivablePercentageOnNetSalesAndProceeds
Namespace Prefix: | xoma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The specified percentage of domestic net sales of which the entity received the right to receive a portion under the agreement, if amount is greater than international net sales. + References No definition available. + Details
Name: | xoma_RightsReceivableSpecifiedPercentageOfNetSalesDomestic
Namespace Prefix: | xoma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The specified percentage of international net sales of which the entity received right to receive a portion under the agreement, if amount is greater than domestic net sales. + References No definition available. + Details
Name: | xoma_RightsReceivableSpecifiedPercentageOfNetSalesInternational
Namespace Prefix: | xoma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The specified percentage of proceeds from a potential Priority Review Voucher of which the entity received right to receive a portion under the agreement. + References No definition available. + Details
Name: | xoma_RightsReceivableSpecifiedPercentageOfProceeds
Namespace Prefix: | xoma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty and commercial payment receivables under cost recovery method probable and reasonably estimable to be received after one year or beyond the normal operating cycle, if longer. + References No definition available. + Details
Name: | xoma_RoyaltyAndCommercialPaymentReceivablesCostRecoveryMethodLongTerm
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Royalty and commercial payment receivables under cost recovery method probable and reasonably estimable to be received within one year or the normal operating cycle, if longer. + References No definition available. + Details
Name: | xoma_RoyaltyAndCommercialPaymentReceivablesCostRecoveryMethodShortTerm
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=xoma_RoyaltyFinancingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=xoma_CastleCreekBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |